Veeral Sheth

1.9k total citations · 1 hit paper
37 papers, 537 citations indexed

About

Veeral Sheth is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Veeral Sheth has authored 37 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Ophthalmology, 27 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Veeral Sheth's work include Retinal Diseases and Treatments (23 papers), Retinal Imaging and Analysis (22 papers) and Retinal and Optic Conditions (12 papers). Veeral Sheth is often cited by papers focused on Retinal Diseases and Treatments (23 papers), Retinal Imaging and Analysis (22 papers) and Retinal and Optic Conditions (12 papers). Veeral Sheth collaborates with scholars based in United States, Switzerland and United Kingdom. Veeral Sheth's co-authors include Seenu M. Hariprasad, Michael Singer, Parth A. Patel, Sam E. Mansour, Cheng Jiao, David Eichenbaum, Tommy Bui, Brandon Coughlin, Víctor H. González and Vaibhav Tiwari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Ophthalmology.

In The Last Decade

Veeral Sheth

33 papers receiving 527 citations

Hit Papers

The real-world efficacy and safety of faricimab in neovas... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veeral Sheth United States 14 394 305 117 58 40 37 537
João Paulo Castro Sousa Portugal 15 406 1.0× 270 0.9× 100 0.9× 38 0.7× 16 0.4× 44 510
Valentina Sarao Italy 18 803 2.0× 522 1.7× 130 1.1× 44 0.8× 14 0.3× 51 920
Kumiko Nakao Japan 18 585 1.5× 385 1.3× 78 0.7× 87 1.5× 30 0.8× 40 707
Sharmila S. Boekhoorn Netherlands 9 583 1.5× 437 1.4× 127 1.1× 62 1.1× 63 1.6× 13 665
Takeshi Naito Japan 12 428 1.1× 276 0.9× 143 1.2× 92 1.6× 15 0.4× 38 576
Matthew A. Cunningham United States 10 252 0.6× 141 0.5× 68 0.6× 29 0.5× 26 0.7× 14 375
Lebriz Altay Germany 15 701 1.8× 431 1.4× 180 1.5× 29 0.5× 121 3.0× 33 804
Glenn J. Jaffe United States 12 336 0.9× 210 0.7× 87 0.7× 49 0.8× 20 0.5× 19 452
Xiu Hua Wan China 13 343 0.9× 273 0.9× 124 1.1× 232 4.0× 14 0.3× 46 498
Vijay Savant United Kingdom 11 266 0.7× 196 0.6× 33 0.3× 25 0.4× 23 0.6× 18 361

Countries citing papers authored by Veeral Sheth

Since Specialization
Citations

This map shows the geographic impact of Veeral Sheth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veeral Sheth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veeral Sheth more than expected).

Fields of papers citing papers by Veeral Sheth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veeral Sheth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veeral Sheth. The network helps show where Veeral Sheth may publish in the future.

Co-authorship network of co-authors of Veeral Sheth

This figure shows the co-authorship network connecting the top 25 collaborators of Veeral Sheth. A scholar is included among the top collaborators of Veeral Sheth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veeral Sheth. Veeral Sheth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eichenbaum, David, Arshad M. Khanani, Dante J. Pieramici, et al.. (2025). Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. American Journal of Ophthalmology. 275. 14–26.
3.
Danzig, Carl J., David Eichenbaum, Amy Ewald, et al.. (2024). Screen Failures in Clinical Trials in Retina. Ophthalmology Retina. 8(11). 1093–1099. 1 indexed citations
4.
Khanani, Arshad M., Peter K. Kaiser, Margaret Chang, et al.. (2024). Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy. Ophthalmology Retina. 8(11). 1052–1060. 9 indexed citations
5.
Sheth, Veeral, Nancy M. Holekamp, Arshad M. Khanani, et al.. (2024). Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections. Ophthalmology Retina. 9(4). 330–342.
6.
Anderson, Abigail, et al.. (2024). Quantifying Fluid and Function in Suboptimal Responders Switched From an Anti-vascular Endothelial Growth Factor (VEGF) to Faricimab. Cureus. 16(3). e56652–e56652. 2 indexed citations
7.
Patel, Parth A., et al.. (2023). Examining the Role of Telemedicine in Diabetic Retinopathy. Journal of Clinical Medicine. 12(10). 3537–3537. 8 indexed citations
8.
Guymer, Robyn H., Clare Bailey, Voraporn Chaikitmongkol, et al.. (2023). Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice. SHILAP Revista de lepidopterología. 4(3). 100442–100442. 3 indexed citations
9.
Jiao, Cheng, et al.. (2023). Evaluating the Artificial Intelligence Performance Growth in Ophthalmic Knowledge. Cureus. 15(9). e45700–e45700. 29 indexed citations
10.
Singh, Rishi P., Mark Barakat, Michael S. Ip, et al.. (2023). Efficacy and Safety of Brolucizumab for Diabetic Macular Edema. JAMA Ophthalmology. 141(12). 1152–1152. 16 indexed citations
11.
Poor, Stephen, Georges Weissgerber, Christopher M. Adams, et al.. (2022). A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology. 239. 180–189. 13 indexed citations
12.
Patel, Parth A., et al.. (2022). Telemedicine for Retinal Disease During the COVID-19 Pandemic: Survey of the Patient Perspective. Ophthalmology and Therapy. 11(5). 1925–1936. 8 indexed citations
13.
Singer, Michael, Veeral Sheth, Sam E. Mansour, Brandon Coughlin, & Víctor H. González. (2022). Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema. Ophthalmology. 129(6). 605–613. 33 indexed citations
14.
Aziz, Aamir, Arshad M. Khanani, Nikolas London, et al.. (2021). Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study. Investigative Ophthalmology & Visual Science. 62(8). 451–451. 8 indexed citations
15.
Sheth, Veeral. (2021). Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates a Continued Reduction in the Mean Rate of Geographic Atrophy Growth: 18-Month Results from the GATHER1 Clinical Trial. Investigative Ophthalmology & Visual Science. 62(8). 333–333. 1 indexed citations
16.
Oh, Daniel J., Veeral Sheth, Gerald A. Fishman, & Michael A. Grassi. (2020). Simplex Crumbs Homologue 1 Maculopathy Masquerading as Juvenile X-Linked Retinoschisis in Male Patients. Journal of VitreoRetinal Diseases. 4(5). 437–440. 2 indexed citations
17.
Horton, Mark, Christopher J. Brady, Jerry D. Cavallerano, et al.. (2020). Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition. Telemedicine Journal and e-Health. 26(4). 495–543. 47 indexed citations
18.
Yu, Hannah J., Daniel F. Kiernan, David Eichenbaum, Veeral Sheth, & Charles C. Wykoff. (2020). Home Monitoring of Age-Related Macular Degeneration. Ophthalmology Retina. 5(4). 348–356. 20 indexed citations
19.
Afshar, Armin R., et al.. (2013). Cystoid Macular Edema Associated With Fingolimod Use for Multiple Sclerosis. JAMA Ophthalmology. 131(1). 103–103. 25 indexed citations
20.
Vályi-Nagy, Tibor, Veeral Sheth, Christian Clément, et al.. (2004). Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Current Eye Research. 29(4-5). 303–309. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026